Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Recruiting Observational Study
Liver Cancer Liver Metastases Liver Metastasis Colon Cancer Hepatocellular Carcinoma
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 110
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Leiden University Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor. The long-term objective is to establish thermal ablation as the treatment of choice for the vast majority of patients w…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years or above * Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT) * Informed consent Exclusion Criteria: * Patients lacking capacity to give informed consent.
Contacts

Coosje A. M. Verhagen, Drs.

+31-71-5264376

c.a.m.verhagen@lumc.nl

CONTACT

Ariadne L. Velden, van der, Drs.

+31(0)43-3876910

lisa.van.der.velden@mumc.nl

CONTACT